Focal nodular hyperplasia: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| Line 10: | Line 10: | ||
==[[Focal nodular hyperplasia classification|Classification]]== | ==[[Focal nodular hyperplasia classification|Classification]]== | ||
==[[Focal nodular | ==[[Focal nodular hyperplasia pathophysiology|Pathophysiology]]== | ||
==[[Focal nodular hyperplasia causes|Causes]]== | ==[[Focal nodular hyperplasia causes|Causes]]== | ||
| Line 18: | Line 18: | ||
==[[Focal nodular hyperplasia epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Focal nodular hyperplasia epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Focal nodular | ==[[Focal nodular hyperplasia risk factors|Risk Factors]]== | ||
==[[Focal nodular hyperplasia screening|Screening]]== | ==[[Focal nodular hyperplasia screening|Screening]]== | ||
Revision as of 15:23, 18 July 2016
Template:Focal nodular hyperplasia
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Focal nodular hyperplasia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram |X Ray | CT | MRI | | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies